Development of novel "immune stealth" nanotechnology for gene therapy of hemophilia: pre-clinical validation and underlying mechanisms

Medicine & Life Sciences

1. Blood Coagulation Factors 30%
2. Essential Genes 10%
3. Fees and Charges 87%
4. Genetic Therapy 81%
5. Hemophilia A 100%
6. Hemorrhage 5%
7. Immune System 7%
8. Injections 5%
9. Nanotechnology 94%
10. Quality of Life 5%